BRIDGEWAY CAPITAL MANAGEMENT, LLC - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 40 filers reported holding PYXIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$470,028
-35.8%
236,195
-17.5%
0.01%
-38.9%
Q2 2023$732,659
+7.3%
286,195
+68.1%
0.02%0.0%
Q1 2023$682,883
+199.3%
170,2950.0%0.02%
+200.0%
Q4 2022$228,195
-3.7%
170,295
+41.6%
0.01%0.0%
Q3 2022$237,000
+41.9%
120,295
+71.1%
0.01%
+50.0%
Q2 2022$167,00070,2950.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Yu Fan 69,303$137,9129.78%
Decheng Capital Management III (Cayman), LLC 326,810$650,3520.22%
Harvest Investment Services, LLC 113,894$226,6490.15%
Laurion Capital Management LP 3,170,803$6,309,8980.04%
CORNERCAP INVESTMENT COUNSEL INC 74,903$149,0570.03%
SCHULHOFF & CO INC 22,000$43,7800.02%
HHLR ADVISORS, LTD. 382,606$761,3860.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 236,195$470,0280.01%
ExodusPoint Capital Management, LP 415,072$8260.01%
Bleakley Financial Group, LLC 11,234$22,3560.00%
View complete list of PYXIS ONCOLOGY INC shareholders